Will Novo Nordisk Be a $1 Trillion Company by 2030?

Submitted by admin on January 30, 2024 - 10:40am

Source:

Motley Fool

News Tags:

Headline:

snippet:

Novo Nordisk stock surged over 50% in 2023, in large part because of its medications used in weight loss.
While the company has a solid foundation in the diabetes and obesity markets, competition is rising.
Novo Nordisk is looking to expand its portfolio in areas including cardiovascular and kidney diseases.

Search form